Home  >  About the System   >  News & Media Relations  >  News  >  News List

About Munson Healthcare

  • Advocacy
  • Ask-A-Nurse
  • Submit A Question
  • Careers
  • Clinical Research
  • Committed to You
  • Community Commitment
  • Community Health
  • Contact Us
  • Diversity, Equity & Inclusion
  • Information Security
  • Leadership
  • News & Media Relations
  • In the Media
  • Media Contacts
  • Media Policies & Resources
  • COVID-19 Newsroom
  • Stroke Media
  • Sponsorship Requests
  • Newsletter Sign-Up
  • Volunteer

    • Pulmonary Function Testing Now Available in Charlevoix

     January 8, 2024 Munson Healthcare Charlevoix Hospital is pleased to announce the addition of Pulmonary Function Testing (PFT) services to its comprehensive healthcare offerings. This new service is part of Munson Healthcare’s Regional Care Transformation Plan and reflects the hospital's ongoing...

    Cerner Hospitals: Updates to COPD and Pneumonia PowerPlan Antibiotic Durations

     December 7, 2023 As clinical outcomes literature shows shorter courses of antibiotic therapy are as effective as longer courses for COPD and pneumonia, the following durations have been added to antibiotic orders in the COPD and Pneumonia Cerner PowerPlans: 3 Days: Treatment of COPD and...

    Pharmacy Shortage: Injectable Corticosteroids

     May 18, 2023 Injectable hydrocortisone and methylprednisolone are currently on backorder with next predicted release in early June. Providers are asked to consider: Use of oral options or IV dexamethasone whenever appropriate. Maximum repeat doses of 40mg methylprednisolone for most...

    Pulmonary & Critical Care of Northwest Michigan Joins Munson Healthcare

     October 6, 2021 Pulmonary & Critical Care of Northwest Michigan, located at 5087 N. Royal Dr., Ste. B, Traverse City, has joined Munson Healthcare. The new name for the practice is Munson Healthcare Pulmonary & Critical Care of Northwest Michigan. The providers, location, and phone number remain the...

    FDA Expands Monoclonal Antibody Therapy Referral Criteria

     May 18, 2021 The one-time Monoclonal Antibody (mAb) Therapy (infusion) is available for treating providers to order for qualifying high-risk outpatients diagnosed with COVID-19 and we currently have many openings available. The FDA has expanded the criteria for referring a patient to Monoclonal Antibody...
    Load More